Have you noticed hiccups after dose increases or when taking another new medicine
While it is too early to call an end to compounding, potential intervention by the FDA and DOJ could support the branded GLP-1 market, Flynn says
In an accompanying editorial, two medical experts at the University of Pittsburgh, Elizabeth Oczypok and Timothy Anderson, suggest that this new class of drugs should be rebranded from weight loss drugs to weight management drugs, which people may need to take indefinitely
But the best option depends on you
I also explain how to determine the right sodium intake for your individual needs and discuss why some people may benefit from increasing salt and other electrolytes
As a result, semaglutide continues to be recognized as the leading GLP-1 option for patients seeking evidence-based, medically supervised weight management in 2026